Carlson Named NuGene International CEO

Steve Carlson has been named CEO and president of NuGene International, Inc, a developer, manufacturer and marketer of skin and hair care lines utilizing adipose derived (non-embryonic) human stem cell conditioned media. Carlson began his career at Allergan. During his 15 year tenure he rose to the position of senior vice president of marketing, where he lead the licensing, development and early commercialization of Botox.  Carlson subsequently served as CEO, president and director of Obagi Medical Products, a global pharmaceutical skin care line where he successfully led the company’s public offering in 2006. Valeant Pharmaceuticals ultimately acquired Obagi Medical Products for over $400 million. Carlson's experience includes a broad number of medical industries with consumer and patient brands in ophthalmology, dermatology, plastic surgery, orthopedics and neurology.

“Steve has a history of building world class organizations by bringing people together who can rapidly and creatively commercialize new technologies,” said NuGene Co-Founder Ali Kharazmi. “This is a huge win for NuGene. We are excited to have him take the lead role with our unique stem cell technology.”